Drug recall · February 12, 2020
Desmopressin Acetate Tablets recall
Why: GMP Deviations: Product bottle may be absent of desiccant.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Desmopressin Acetate Tablets, 0.2 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2465-01
- Lots / codes
Lot #: 1269726M, exp. date 01/2020; 1283269M, 1283270M, exp. date 03/2020; 1292992M,1292993A, exp. date 04/2020
- Quantity
- 69,012 bottles
- Company
- Teva Pharmaceuticals USA, Parsippany, NJ
- Distribution
- Nationwide within the United States
- Initiated
- January 27, 2020 · Voluntary: Firm initiated
- Classified
- February 6, 2020
- Reported
- February 12, 2020
- Ended
- December 10, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Desmopressin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.